Testing a wearable device to prevent foot ulcers in people with diabetes

This trial is testing a wearable device called Path Active™ that monitors temperature and pressure changes in your feet to catch early warning signs of foot problems before they become serious ulcers. Half of the participants will wear the Path Active device (which sends alerts to your phone and your doctor), while the other half will receive their usual podiatry care. The study will run for 12 weeks to see if the device helps prevent foot ulcers better than standard checkups alone.

Foot ulcers are a major complication of diabetes—affecting about 1 in 7 people with diabetes—and they can lead to amputation and serious health risks. Currently, people at high risk wait for scheduled appointments with foot specialists, sometimes missing early warning signs. This medication aims to catch problems earlier by continuously monitoring your feet and alerting your care team immediately when changes occur.